Latest Breaking News On - Thrombolytic therapy - Page 1 : comparemela.com

Benefit of Late Thrombolysis in Large Vessel Strokes?

Some patients with large vessel occlusion strokes may still benefit from thrombolysis even after the traditional 4.5-hour window, new analysis of the TIMELESS trial suggested.

Adding Antithrombotic to tPA Does Not Improve Stroke Outcome

Argatroban and eptifibatide were ineffective as adjunctive therapies to thrombolysis in patients with ischemic stroke in the MOST trial.

Global Venous Thromboembolism Market Forecast 2024-2033 – Market Size, Drivers, Trends, And Competitors

Tenecteplase Non-inferior to Alteplase in Stroke: ATTEST-2

This result, along with its ease of use, adds to the growing evidence that tenecteplase should be a first-line thrombolytic agent, trial investigators say.

Tenecteplase a First-Line Thrombolytic for LVO Stroke?

Tenecteplase confers similar reperfusion, safety, and functional outcomes as alteplase in patients with large-vessel occlusion stroke, new research shows.